How to Buy Avalo Therapeutics Stock
Avalo Therapeutics Inc
Avalo Therapeutics, Inc. , a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases.
Avalo Therapeutics stock last closed at $4.84, down 0.82% from the previous day, and has decreased 58.38% in one year. It has overperformed other stocks in the Biotechnology industry by 0.18 percentage points. Avalo Therapeutics stock is currently +42.77% from its 52-week low of $3.39, and -69.75% from its 52-week high of $16.00.
As of Jun 13, 2025, there are 10.83M AVTX shares outstanding. The market value of AVTX is $52.41M. In the last 24 hours, 44,200 AVTX shares were traded.
How to Buy Avalo Therapeutics Stock
Not sure how to invest in Avalo Therapeutics stock? Here's how.
- Figure out where to buy Avalo Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Avalo Therapeutics stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your investment account: Choose your payment method and add your details.
- Research Avalo Therapeutics stock: The Avalo Therapeutics ticker symbol is AVTX. Is Avalo Therapeutics stock a good investment? Should you buy shares of AVTX? How do AVTX's underlying business fundamentals look? Do top analysts think Avalo Therapeutics is a good buy? Why has AVTX's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if AVTX is a good stock to buy).
- Execute your AVTX buy order: Decide if you will purchase AVTX shares at the current market price or use a limit order to buy AVTX shares at a specific price.
- Get updates on your AVTX investment: Create a watchlist to important updates regarding your investment in Avalo Therapeutics shares.
Step 1: Figure out where to buy Avalo Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy AVTX shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Tech to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal information so you can buy AVTX today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open a new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have filled out your info on the highest rated stock app, you need to deposit funds:
Check out this video walkthrough to see the process of depositing money into your investment account.
Step 4: Research Avalo Therapeutics stock
Once you have decided on the best place to buy Avalo Therapeutics stock, it's very important to analyze their stock before you invest, so you truly understand the risk and upside.
Avalo Therapeutics Metrics
Avalo Therapeutics Fundamentals
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on AVTX's stock page.
Is AVTX stock undervalued or overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge AVTX's true value.
Using relative valuations methods:
- AVTX could be undervalued based on its P/B ratio of 0.43x, relative to Biotechnology industry P/B ratio of 4.66x
You can access additional valuation research on AVTX's stock here.
How do AVTX Financials look?
Pros:
- AVTX has $125.11M in cash and short term investments. This is enough to cover its annual cash burn of $52.31M.
- There are more short-term assets than short-term liabilities on the AVTX balance sheet.
- There are more short-term assets than long-term liabilities on the AVTX balance sheet.
- Total AVTX debt is lower than 5 years ago, relative to shareholder equity.
- AVTX has cash burn of 52311000. It has enough cash and short-term investments to cover this for at least one year.
- AVTX profit margin has gone up from -9,853.7% to 16,556% in the past year.
- AVTX has a low debt to equity ratio of 0.13.
Is AVTX stock a Buy, Hold, or Sell, according to analysts?
Out of 6 sell side analysts who research AVTX, the consensus analyst rating on AVTX is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they investment advice.
Latest AVTX Analyst Forecasts
Dev Prasad, a bottom 19% analyst from LUCID CAPITAL MARKETS initiates coverage on AVTX with a strong buy rating and announces their AVTX price target of $24.00, on Dec 17, 2024.
You can dive deeper into what analysts are saying on the Avalo Therapeutics stock forecast page.
AVTX Technical Indicators
Is AVTX Making Money?
Last year, AVTX revenue was $441.00k. During the past five year, AVTX's revenue has grown by -42.35% per year. This was slower than the Biotechnology industry average of 43.24%.
Dive into AVTX's earnings and revenue performance here.
Who is buying/selling AVTX?
In the past year, executives and large shareholders at AVTX have sold more shares than they have bought.
Garry Arthur Neil, Chief Executive Officer of AVTX, was the latest AVTX insider to sell. They sold $150,478.02 worth of AVTX stock on Mar 28, 2025.
Learn more about who owns AVTX shares here.
Does AVTX stock generate passive income?
No, Avalo Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about AVTX?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your AVTX buy order
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given dollar amount, place a limit order.
Press the Open button and your broker will place the order.
If you need more assistance buying stocks on eToro, click the helpful video below:
Step 6: Get updates on your AVTX investment
Now that you own some AVTX stock, you'll want to stay up-to-date on your new investment.
Create a watchlist to monitor your AVTX stock.
AVTX Feed
How to Buy Stock in Avalo Therapeutics
To reiterate, here are the 6 steps to buy stock in Avalo Therapeutics:
- Figure out where to buy Avalo Therapeutics stock
- Create your brokerage account
- Put funds into your investment account
- Research Avalo Therapeutics stock
- Execute your AVTX buy order
- Get updates on your AVTX investment
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep track of your new investment in Avalo Therapeutics, create a watchlist today.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.